1. Home
  2. HOWL vs LODE Comparison

HOWL vs LODE Comparison

Compare HOWL & LODE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOWL
  • LODE
  • Stock Information
  • Founded
  • HOWL 2017
  • LODE 2008
  • Country
  • HOWL United States
  • LODE United States
  • Employees
  • HOWL N/A
  • LODE N/A
  • Industry
  • HOWL Biotechnology: Pharmaceutical Preparations
  • LODE Major Chemicals
  • Sector
  • HOWL Health Care
  • LODE Industrials
  • Exchange
  • HOWL Nasdaq
  • LODE Nasdaq
  • Market Cap
  • HOWL 53.4M
  • LODE 53.0M
  • IPO Year
  • HOWL 2021
  • LODE N/A
  • Fundamental
  • Price
  • HOWL $1.25
  • LODE $3.60
  • Analyst Decision
  • HOWL Strong Buy
  • LODE Buy
  • Analyst Count
  • HOWL 3
  • LODE 1
  • Target Price
  • HOWL $8.33
  • LODE $26.00
  • AVG Volume (30 Days)
  • HOWL 549.7K
  • LODE 453.6K
  • Earning Date
  • HOWL 08-07-2025
  • LODE 08-07-2025
  • Dividend Yield
  • HOWL N/A
  • LODE N/A
  • EPS Growth
  • HOWL N/A
  • LODE N/A
  • EPS
  • HOWL N/A
  • LODE N/A
  • Revenue
  • HOWL $1,143,000.00
  • LODE $3,376,027.00
  • Revenue This Year
  • HOWL N/A
  • LODE $33.58
  • Revenue Next Year
  • HOWL N/A
  • LODE N/A
  • P/E Ratio
  • HOWL N/A
  • LODE N/A
  • Revenue Growth
  • HOWL N/A
  • LODE 102.20
  • 52 Week Low
  • HOWL $0.60
  • LODE $1.26
  • 52 Week High
  • HOWL $4.18
  • LODE $10.10
  • Technical
  • Relative Strength Index (RSI)
  • HOWL 45.36
  • LODE 51.45
  • Support Level
  • HOWL $1.03
  • LODE $3.57
  • Resistance Level
  • HOWL $1.10
  • LODE $3.86
  • Average True Range (ATR)
  • HOWL 0.07
  • LODE 0.23
  • MACD
  • HOWL -0.02
  • LODE -0.05
  • Stochastic Oscillator
  • HOWL 22.81
  • LODE 37.25

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

About LODE Comstock Inc.

Comstock Inc innovates and commercializes technologies that are deployable across entire industries to contribute to energy abundance by efficiently extracting and converting under-utilized natural resources, such as waste and other forms of woody biomass into renewable fuels, and end-of-life electronics into recovered electrification metals. Comstock's innovations group is engaged in developing and using artificial intelligence technologies for advanced materials development.

Share on Social Networks: